Herb Spanfellner

Herb Spanfellner has a diverse work experience spanning over several years. Herb started their career as an Assistant Chemist at Boehringer Ingelheim - Roxane Labs in 1989. Herb was responsible for stability testing and supervision of method development chemists. Herb then moved on to become the Section Head at Boehringer Ingelheim - Roxane Laboratories, Inc, where they helped design and staff a new Stability Department.

In 1998, Herb joined Cephalon as a Laboratory Manager, responsible for coordinating testing and release of pharmaceutical products. Herb later took on roles as Sr. Manager and Director of Quality Control Laboratory, overseeing multiple analytical laboratories. Herb managed the stability program for seven Cephalon products.

In 2012, Herb joined Teva Pharmaceuticals as the Director of TUSA Risk Assessment for Manufactured Pharmaceuticals (RAMP), where they directed the Quality Risk Management program for North American operations. Herb ensured compliance with risk program requirements and coordinated risk assessments with global manufacturing sites.

From 2015 to 2016, Herb worked as a Senior Consultant at Validant, providing consulting services.

In 2016, they became the Director of Quality Assurance at Iroko Pharmaceuticals, LLC, providing strategic and tactical direction to the company's QA department. Herb collaborated cross-functionally and supported commercial manufacturing activities worldwide.

Herb's most recent role has been with Adaptimmune, where they started as the Director of Quality Control in 2017 and later became the Senior Director of Quality Control Global Operations.

Herb Spanfellner completed their Bachelor's degree in Chemistry from The Ohio State University, studying from 1984 to 1989. Prior to that, they attended GHS, but no specific details about their degree or field of study at this school are available.